Browse by Title

Type here to filter the list

N
New Directions in Coagulation Management and Transfusion Practice with Viscoelastic Testing in the OR (AM24-SN-02-L)

Favorite

Timothy C. Carll, MD (he/him/his) – University of Chicago ### 2362144###Speaker###Assistant Professor, Pathology / Transfusion, Hemostasis, & Apheresis Medicine###University of Chicago###
Speaker: Timothy C. Carll, MD (he/him/his) – University of Chicago
### he/him/his @@@ Katherine Forkin, MD (she/her/hers) – University of Virginia ### 2362145###Speaker###Liver Transplant Anesthesiology Division Chief, Associate Professor of Anesthesiology###University of Virginia###
Speaker: Katherine Forkin, MD (she/her/hers) – University of Virginia
### she/her/hers @@@ Zhen W. Mei, MD – David Geffen School of Medicine at University of California Los Angeles ### 2118763###Program Chair###Health Sciences Assistant Clinical Professor###David Geffen School of Medicine at University of California Los Angeles###
Program Chair: Zhen W. Mei, MD – David Geffen School of Medicine at University of California Los Angeles
### AM24-SN-02-L
No Evidence of Anti-D Alloimmunization After RhD-Positive Apheresis Platelet Transfusion to RhD-Negative Pediatric, Adolescent and Young Adults without RhIg Prophylaxis (OA3-AM24-MN-07)
Favorite

Kristina Prus, MD (she/her/hers) – Cincinnati Children's Hospital Medical Center ### 2418362###Presenting Author###Director of Transfusion Services, Section Director of Clinical Coagulation Testing Laboratory, Medical Director of the Cellular Manipulation Laboratory###Cincinnati Children's Hospital Medical Center###
Presenting Author: Kristina Prus, MD (she/her/hers) – Cincinnati Children's Hospital Medical Center
### she/her/hers OA3-AM24-MN-07
Novel Anticoagulant/Additive Solution Maintains the Hemostatic Function of Cold Stored Whole Blood for 56 Days (OA3-AM24-SN-23)
Favorite

Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 837000###Presenting Author###Executive Director, Connell and O'Reilly Families Cell Manipulation Core Facility###Dana-Farber Cancer Institute, Harvard Medical School###
Presenting Author: Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his OA3-AM24-SN-23